Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Karen Addington awarded MBE in King’s Birthday Honours
Karen Addington, CEO of Breakthrough T1D UK, has been awarded the Member of the Order of the British Empire (MBE) in the 2025 King’s Birthday Honours List, in recognition of her exceptional services to people with type 1 diabetes.
The award recognises Karen’s dedication and impact over the past 20 years at Breakthrough T1D, where, through her determined leadership, she has propelled the organisation through remarkable growth and change.
As both a respected thought leader among stakeholders and an inspirational presence at community events, Karen has become a trusted and central figure within the type 1 diabetes community. Because of her leadership, the charity has more than quadrupled its investment in research and expanded its reach to support thousands of people and families.
She has championed real, practical advances in treatment, helping to expand access to technologies like continuous glucose monitoring (CGM) and hybrid closed loop (HCL) systems which help deliver insulin automatically.
At the same time, Karen has kept the search for a cure firmly at the heart of Breakthrough T1D’s mission, ensuring Breakthrough T1D continues to fund and drive the most promising global research. Her ongoing commitment is creating meaningful change for everyone affected by type 1 diabetes.
She has inspired strategic impact and collaboration in the UK and internationally, among researchers, policy makers and people living with T1D. In 2024 she led the organisational rebranding from Juvenile Diabetes Research Foundation (JDRF) to Breakthrough T1D, reflecting the determination to prevent, treat and cure T1D.
Reacting to the announcement, Karen said: “I’m truly honoured and a little overwhelmed to receive this recognition. But this award really belongs to the incredible type 1 diabetes community and the dedicated team I’m lucky to work alongside. I’ve just played a small part in something much bigger, supporting people living with T1D and pushing for progress in care, understanding and research. I’m grateful every day to be part of this important work.”
Phil Aird-Mash, Breakthrough T1D Chair, said: “This is a well-deserved recognition of Karen’s extraordinary passion and commitment to the global type 1 diabetes community. Over the years, she has driven remarkable progress in both treatments and research, helping to transform the landscape of T1D care. Her work has supported many thousands of people living with T1D and their families and fuelled hope for a cure. Thank you Karen, for everything that you have accomplished in your time at Breakthrough T1D.”
Karen will receive the award at a formal investiture ceremony later this year.
Learn more about insulin pumps, continuous glucose monitors, smart insulin pens and hybrid closed loop systems.
Find out about our work to make T1D treatments available to everyone who needs or wants them.
Find out about our research to find cures for T1D and make everyday life better for those who face it.
We look at a new feature coming to the CamAPS FX app, which will allow users to remove the need to count carbohydrates before a meal.
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.
Highlights from an extraordinary year in type 1 diabetes (T1D) research, treatment, advocacy and policy.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
Would you like to visit the website of our {{ affiliate_country }} affiliate to complete your action?
